- Topics, Trends & Updates for May (5/5/22)
- New Guidance: Adopting a Patient-Centered Approach to Sexual Health (4/28/22)
- New Guidance: Questions, Answers, and Best Practices for Expedited Partner Therapy (EPT) (4/19/22)
- Updated: Use of Injectable CAB/RPV LA as Replacement ART in Virally Suppressed Adults (4/7/22)
- Updated: Screening for Cervical Dysplasia and Cancer in Adults With HIV (3/29/22)
- Updated: Mycoplasma genitalium Management in Adults (3/28/22)
- Updated: Screening for Anal Dysplasia and Cancer in Adults With HIV (2/22/22)
- New Guideline: Therapeutic Use of Medical Cannabis in New York State (1/25/22)
- Updated: COVID-19 Vaccine for Adults With HIV (1/12/22)
- Updated: Perioperative Care in Adults With HIV (11/16/21)
- Updated: Selecting An Initial ART Regimen (10/11/21)
- Updated: When to Initiate ART, With Protocol for Rapid Initiation (10/11/21)
- Updated: Diagnosis and Management of HIV-2 in Adults (10/11/21)
- Medscape Interviews Dr. Elliot DeHaan, Lead Author of New Guideline on CAB/RPV LA (8/3/21)
- Medscape Commentary: IRIS: 'Why Is My Patient Getting Worse?' (7/29/21)
- Updated Resource: ART Drug-Drug Interactions (7/20/21)
- Updated Guideline: Diagnosis and Management of Acute HIV Infection (7/20/21)
- New Guideline: Substance Use Disorder Treatment in Pregnant Adults (7/16/21)
- New Guideline: Use of Injectable CAB/RPV LA as Replacement ART in Virally Suppressed Adults (7/14/21)
- New Recommendation: COVID-19 Vaccine for Adults With HIV (7/13/21)
- Updated Guideline: Laboratory Monitoring for Adverse Effects of ART (6/8/21)
- Updated: Use of Dolutegravir in Individuals of Childbearing Capacity (6/3/21)
- Updated Guideline: Prevention and Management of Hepatitis A Virus in Adults With HIV (5/21/21)
- Medscape Commentary: A Framework for Comprehensive HIV Primary Care (5/19/21)
- What We're Reading: Weight Gain Associated With TAF (5/6/21)
- FDA Expands Eligibility for Pfizer-BioNTech COVID-19 Vaccine Booster Dose to Children 5 through 11 Years (5/17/22)
- FDA Authorizes First COVID-19 Test Available without a Prescription That Also Detects Flu and RSV (5/16/22)
- HIVinfo Releases New HIV and COVID-19 Fact Sheet (5/12/22)
- FDA Limits Use of Janssen COVID-19 Vaccine to Certain Individuals (5/5/22)
- FDA Approves First COVID-19 Treatment for Young Children (4/25/22)
- FDA Authorizes First COVID-19 Diagnostic Test Using Breath Samples (4/14/22)
- NYCDOHMH: CDC Allows Second COVID-19 Boosters for Certain People (3/31/22)
- FDA Authorizes Second Booster Dose of Two COVID-19 Vaccines for Older and Immunocompromised Individuals (3/29/22)
- NYCDOHMH: Updated COVID-19 Vaccination Interval Guidance (3/1/22)
- NYCDOHMH: COVID-19 Vaccine Updates (2/18/22)
- FDA Takes Key Action by Approving Second COVID-19 Vaccine (1/31/22)
- FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron Variant (1/24/22)
- FDA Takes Actions to Expand Use of Treatment for Outpatients with Mild-to-Moderate COVID-19 (1/21/22)
- Free At-Home COVID-19 Tests (1/19/22)
- FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to Five Months (1/7/22)
- FDA Takes Multiple Actions to Expand Use of Pfizer-BioNTech COVID-19 Vaccine (1/3/22)
- NYCDOHMH: mRNA COVID-19 Vaccines Preferred Over Johnson & Johnson (12/23/21)
- FDA EUA for Paxlovid for COVID-19 (12/23/21)
- NYCDOHMH: COVID-19 Boosters Recommended for People Ages 16 and 17 Years (12/16/21)
- FDA Expands Eligibility for Pfizer-BioNTech COVID-19 Booster Dose to 16- and 17-Year-Olds (12/9/21)
- NYCDOHMH: CDC Recommends All Adults May Receive a COVID-19 Booster Dose (11/24/21)
- NYCDOHMH: Update on COVID-19 Vaccine Booster Doses (11/13/21)
- NYCDOHMH: CDC Recommends Pfizer COVID-19 Vaccine for Children Ages 5 to 11 Years (11/6/21)
- FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Children 5 through 11 Years of Age (10/29/21)
- NYCDOHMH: CDC Recommends COVID-19 Vaccine Boosters for Johnson & Johnson and Moderna Recipients (10/23/21)
- NYS Medicaid Update – Special Edition (5/18/22)
- HIVinfo: Updated Resources Available: FDA-Approved HIV Medicines (5/16/22)
- AETC NCRC: May 2022 Monthly Update (5/12/22)
- CEI Newsletter (5/10/22)
- NYSDOH: Hepatitis C (HCV) Dashboard Launches (5/2/22)
- HIVinfo: Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV (4/12/22)
- HIVinfo: Updated HHS Pediatric Antiretroviral Therapy Guidelines Released (4/12/22)
- 2022 AIDS Institute Director Call to Action Letter (3/15/22)
- Now Available: Enhanced Access to STI Clinical Experts Through the CEI Sexual Health Center of Excellence (3/10/22)
- Key Changes in Cannabis Policies: Passage of the Marijuana Regulation and Taxation Act (3/9/22)
- HIVinfo: What’s New in the COVID-19 and HIV Guidance (2/22/22)
- HIVinfo: Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV (2/17/22)
- HIVinfo: Updated Resources Available: HIV and Opportunistic Infections, Coinfections, and Conditions (1/26/22)
- NYSDOH AI Letter from the Director: Increase of Congenital Syphilis in NYS (1/25/22)
- HIVinfo: Updates to the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV (1/24/22)
- HIVinfo: Updated Resources Available: Living with HIV and HIV and Specific Populations (1/21/22)
- HIVinfo: Updates to Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the US (12/30/21)
- FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention (12/20/2021)
- FDA: Possible False RPR Reactivity with BioPlex 2200 Syphilis Total & RPR Test Kit Following a COVID-19 Vaccine (12/20/21)
- HIVinfo: Updated Resources Available: The Basics of HIV and AIDS and HIV Prevention (12/16/21)
- NYSDOH AI: HCV Testing in Pregnant Persons Dear Colleague Letter (11/3/21)
- HIVinfo: New HIV Source Web Portal (10/29/21)
- PrEP Aware Week 2021: More to Learn (10/29/21)
- HIVinfo Updated Fact Sheets on HIV and Lipodystrophy, HIV and Older People, HIV and Hepatitis C (9/23/21)
- PrEP Aware Week -- Save the Dates: October 25 to 31 (9/17/20)
- 05/25/2022: HCV and Drug User Health COE ECHO: HCV and Injection Drug Use
- 05/25/2022: HIV Primary Care and Prevention COE: Pre-Exposure Prophylaxis (PrEP)
- 05/31/2022: HepCure & HCV and Drug User Health COE: Hepatitis C and HIV Coinfection
- 06/06/2022: 8th Annual NYS Sexual Health Conference: Directions, Perspectives, and Predictions
- 06/06/2022: HCV and Drug User Health COE: X-Express: Buprenorphine Prescribing for Beginners
- 06/24/2022: NYS HIV Primary Care and Prevention Annual Conference
- 05/19/2022: Empire Liver Foundation: Hepatitis C in People of Reproductive Age, Pregnancy and Children
- 05/19/2022: MATEC: Long COVID and HIV – The Evolution of Science, Best Practices and Health Justice
- 05/19/2022: NEAETC: Mental Health and HIV Webinar Series Part 2: Pharmacotherapy for Depression
- 05/25/2022: HRSA HAB: AccessTA Technical Assistance Virtual Open House
- 05/26/2022: HRSA HAB: AccessTA Technical Assistance Virtual Open House
- 05/26/2022: NEAETC: Mental Health and HIV Webinar Series Part 3: Anxiety Disorders
- 05/31/2022: NECA AETC: Engagement Retention Strategies for Working with Women with HIV
- 06/01/2022: NYSDOH AI: Integrated HIV Prevention and Care Plan Development: Community Engagement Opportunity
- 06/03/2022: NAHEWD: When you can’t stop the party… the Syndemic of HIV and Chemsex
- 06/03/2022: NECA AETC: 13th Annual Infectious Disease Update a Hybrid Conference
- 06/07/2022: NYSDOH AI: Integrated HIV Prevention and Care Plan Development: Community Engagement Opportunity
- 06/08/2022: Indiana University National HIV Conference
- 07/29/2022: AIDS 2022 (The 24th International AIDS Conference)
- 08/23/2022: HRSA: National Ryan White Conference on HIV Care & Treatment
- 10/16/2022: IAS-USA: 2022 Ryan White HIV/AIDS Program Clinical Conference